Wells Fargo & Company Biote Corp. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Biote Corp. stock. As of the latest transaction made, Wells Fargo & Company holds 4,733 shares of BTMD stock, worth $37,059. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,733
Previous 4,140
14.32%
Holding current value
$37,059
Previous $20,000
35.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BTMD
# of Institutions
55Shares Held
12.1MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY3.77MShares$29.5 Million10.43% of portfolio
-
Bandera Partners LLC New York, NY2.01MShares$15.7 Million4.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$11 Million0.0% of portfolio
-
Black Rock Inc. New York, NY973KShares$7.62 Million0.0% of portfolio
-
Boston Partners Boston, MA714KShares$5.59 Million0.01% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $59.3M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...